{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:53:57Z","timestamp":1759042437781},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","jaacap.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jaac.2019.03.015","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T05:35:05Z","timestamp":1553146505000},"page":"219-221","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Editorial: Cognitive-Behavioral Therapy Versus Serotonin Reuptake Inhibitors for Pediatric Obsessive-Compulsive Disorder"],"prefix":"10.1016","volume":"59","author":[{"suffix":"Jr.","given":"Joseph","family":"Strayhorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2019.03.015_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaac.2011.09.019","article-title":"American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder","volume":"51","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.015_bib2","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial","volume":"292","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2019.03.015_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaac.2010.10.006","article-title":"Service utilization for lifetime mental disorders in U.S. adolescents: results from the National Comorbidity Survey Adolescent Supplement (NCS-A)","volume":"50","author":"Merikangas","year":"2011","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.015_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jaac.2019.01.010","article-title":"Treatment gains are sustainable in pediatric obsessive-compulsive disorder: three-year follow-up from the NordLOTS","volume":"59","author":"Melin","year":"2020","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.015_bib5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4088\/JCP.v64n0919","article-title":"Paroxetine OCD Study Group. Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine","volume":"64","author":"Hollander","year":"2003","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.015_bib6","first-page":"323","article-title":"An open trial and discontinuation study of fluoxetine in children and adolescents with obsessive-compulsive disorder","volume":"43","author":"Semerci","year":"2001","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.jaac.2019.03.015_bib7","first-page":"810","article-title":"Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors","volume":"52","author":"Frost","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.015_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-3223(98)00126-7","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial","volume":"44","author":"Rosenbaum","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.015_bib9","series-title":"Prozac Backlash: Overcoming the Dangers of Prozac, Zoloft, Paxil, and Other Antidepressants With Safe, Effective Alternatives","author":"Glenmullen","year":"2000"},{"key":"10.1016\/j.jaac.2019.03.015_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000370338","article-title":"Withdrawal symptoms after serotonin reuptake inhibitor discontinuation: a systematic review","volume":"84","author":"Fava","year":"2015","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.jaac.2019.03.015_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4088\/JCP.v64n0204","article-title":"Can long-term treatment with antidepressant drugs worsen the course of depression?","volume":"64","author":"Fava","year":"2003","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.015_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000341178","article-title":"Patient online report of selective serotonin reuptake inhibitor-induced persistent postwithdrawal anxiety and mood disorders","volume":"81","author":"Belaise","year":"2012","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.jaac.2019.03.015_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/JRS-180018","article-title":"SSRI and SNRI withdrawal\u00a0symptoms reported on an Internet forum","volume":"29","author":"Stockmann","year":"2018","journal-title":"Int J Risk Saf Med"},{"key":"10.1016\/j.jaac.2019.03.015_bib14","first-page":"24","article-title":"Identification and treatment of antidepressant tachyphylaxis","volume":"11","author":"Targum","year":"2014","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.jaac.2019.03.015_bib15","first-page":"1","article-title":"Antidepressant use among persons aged 12 and over: United States, 2011-2014","volume":"283","author":"Pratt","year":"2017","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jaac.2019.03.015_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/ajp.156.2.324","article-title":"Are psychiatrists cost-effective? An analysis of integrated versus split treatment","volume":"156","author":"Dewan","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.015_bib17","author":"Kaplan"},{"key":"10.1016\/j.jaac.2019.03.015_bib18","author":"Binder"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856719302011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856719302011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T02:46:54Z","timestamp":1663123614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856719302011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0890856719302011"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2019.03.015","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial: Cognitive-Behavioral Therapy Versus Serotonin Reuptake Inhibitors for Pediatric Obsessive-Compulsive Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2019.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2019.01.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a92019 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}